Neonatal pain control with sucrose or skin to skin care

0

To compare the efficacy of SSC with oral Sucrose for pain management in preterm neonates” Shukla et al (2018).

Abstract:

Objective: To compare the efficacy of SSC with oral Sucrose for pain management in preterm neonates.

Methodology: Parallel-group, assessor-blinded randomized control trial conducted from February-June 2017 at a level 3B-NICU. Hundred preterm neonates (29-0/7 to 36-6/7 weeks gestational age) requiring heel-stick were randomly assigned (1:1), to SSC (50, Group-A) and Sucrose (50, Group-B). In Group-A, SSC was provided at least 10 min before the procedure. In Group-B, 0.2 ml of oral Sucrose was provided 2 min before the procedure. Blinded assessment of Premature Infant Pain Profile (PIPP) score was done 30 s post-procedure using recorded videos.

Results: Baseline variables were gestational age [32.79(2.34) weeks], age [14.04(11.10) days] and birth weight [1.62(0.35) kilograms]. PIPP score was less in group- A vs. B but could not achieve statistical significance .

Conclusions: SSC and Sucrose have comparable efficacy in managing pain in premature neonates.



Reference:

Shukla, V., Chapla, A., Uperiya, J., Nimbalkar, A., Phatak, A. and Nimbalkar, S. (2018) Sucrose vs. skin to skin care for preterm neonatal pain control—a randomized control trial. Journal of Perinatology. August 7th. .

DOI: https://doi.org/10.1038/s41372-018-0193-9

Share.

Comments are closed.